You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cancer
  5. Lung cancer

Pemetrexed for the first-line treatment of non-small-cell lung cancer

  • Technology appraisal guidance
  • Reference number: TA181
  • Published:  23 September 2009
  • Guidance
  • Tools and resources
  • Information for the public
  • History

Lung cancer (non-small-cell, first line treatment) - pemetrexed: Appendix A - provisional matrix of stakeholders

Lung cancer (non-small-cell, first line treatment) - pemetrexed: Appendix A - provisional matrix of stakeholders Lung cancer (non-small-cell, first line treatment) - pemetrexed: Appendix A - provisional matrix of stakeholders
09 October 2014
(100.37 Kb 29 sec)

Adobe Acrobat reader required.

  Adobe Acrobat reader required.

This page was last updated: 09 October 2014

Back to top